n-Lorem Foundation Notes Latest in Guidance From FDA on Developing ASO Drug Products for Patients With Nano-rare Diseases
Guidance issued by [...]
John Maraganore Joins the n-Lorem Foundation Team as Chair of Its Advisory Council
John Maraganore pledges [...]
n-Lorem Foundation Welcomes New Members, Jason Wood and Gene Yeo, to its Board of Directors
Newest members contribute [...]
n-Lorem Foundation Appoints Sarah Glass, Ph.D., as Chief Development Officer
Experienced research geneticist [...]
n-Lorem Foundation Announces Partnership with Nitto Avecia to Strengthen Development of Personalized Medicines for Patients with Ultra-Rare Diseases
World’s largest oligonucleotide [...]
n-Lorem Foundation Welcomes Frank J. Sasinowski to its Board of Directors
Accomplished leader involved [...]
n-Lorem Foundation, ChemGenes Announce Collaboration to Support Manufacturing of Individualized Treatments for Patients with Ultra-Rare Diseases
Foundation’s partnership with [...]
n-Lorem Foundation Partners with Ultragenyx to Bolster Development of Personalized Medicines for Patients with Ultra-Rare Diseases
Foundation’s collaboration with [...]
